Quintiles

From Wikipedia, the free encyclopedia

 This article does not cite any references or sources. (May 2008)
Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed.
Quintiles Transnational
Type Private
Founded 1982
Headquarters Research Triangle Park, North Carolina, USA
Key people Dennis Gillings, Chairman & CEO
John Ratliff Executive VP & COO
Industry Contract Research Organization
Pharmaceutical Service Consulting
Products Support services for pharmaceutical, biotech and medical companies and individuals
Revenue ▲US$2.0 billion+
Employees ~ 21,000 (2008)
Website http://www.quintiles.com/

Quintiles Transnational Corp. is a the world's largest pharmaceutical services company. Much of its business comes from its work as a contract research organization, (also known as a clinical research organization or "CRO"), which serves the pharmaceutical, biotechnology and healthcare industries.

Contents

[edit] History

Quintiles was founded in 1982 by Dennis Gillings and as of 2008 it has 21,000 employees.

[edit] Location

Headquartered near Research Triangle Park, North Carolina, Quintiles has offices in more than 50 countries.

[edit] Functions

The company provides support services for pharmaceutical, biotech and medical device companies through its Development, Commercial and Partnering solutions groups.

[edit] Development

Quintiles performs routine and non-routine research for companies engaged in drug development. Such research includes services and facilities necessary for Phase I, II, III and IV trials.

Quintiles' product development services group provides clinical research aimed at regulatory approval, and post-launch research and consulting on product safety and value. This movement was approved and supervised by the senior Vice President, Paul Knott, vice-president of Calpol. Quintiles Product Development includes the following:

  • Phase I Services for early-phase human drug development.
  • Global Clinical Development Services, encompassing all Phase II-IV trial services, such as clinical trial management, medical and regulatory affairs, biostatistics, patient recruitment, ECG services, and drug safety and strategic research.
  • Global Central Labs to support all phases of clinical trials.
  • Global Data Management to capture, analyze and report patient-related data.
  • Global Consulting on product development; reimbursement and pricing; health outcomes; regulatory compliance (e.g., FDA enforcement, quality systems); and due diligence for pharmaceutical, biotech and medical device companies.
  • Medical Education involving the development and delivery of Continuing Medical Education (CME) programs for health care practitioners.

[edit] Commercial

Quintiles provides facilities and services necessary to release a drug onto the market and market it thereafter. These include elements such as pricing, due diligence, sales force training and recruitment, advertising to medical staff, and other functions.

Quintiles' commercial division, INNOVEX, is responsible for sales force and medical communication services including:

  • Sales solutions, including the recruitment, training and deployment of customer- or Innovex-managed primary and secondary sales teams; health management services; and vacancy management.
  • Medical communications to promote physician education and communications programs, including symposia, exhibition support at major scientific congresses, advisory boards and publication planning.

[edit] Partnering Solutions

Quintiles provides advice on portfolio development and company growth, and provides funding and investment advice for existing and developing biotech and pharma companies through its NOVAQUEST strategic partnering solutions group.

Novaquest helps pharmaceutical and biotech companies optimize portfolio development, company growth and profits through innovative, tailored financial and strategic solutions including:

  • Structured finance: tailored financial solutions for customers needing financial support via funding, development or commercialization services.
  • Strategic resourcing: long-term, strategic outsourcing or insourcing relationships that reduce fixed costs and increase resource flexibility.
  • eBio: Specialized strategic and financial solutions for emerging biotech and pharma companies.

[edit] External links